免疫瘤学在日常实践中的作用
1Gustave Roussy Departement Interdisciplinaire de Soins de Support aux Patients en Onco-hematologie, Villejuif, France.
Current opinion in oncology
|January 27, 2025
概括
一个新的患者护理途径有助于早期检测和管理来自免疫检查点抑制剂 (ICI) 的免疫相关不良事件 (irAE). 这种方法改善了患者的生活质量和治疗遵守,同时减少了严重的毒性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床途径发展发展
背景情况:
- 免疫检查点抑制剂 (ICI) 在瘤学中广泛使用,但可能导致严重的免疫相关不良事件 (irAE).
- 在早期癌症和组合疗法中ICI的扩大使用使毒性管理复杂化.
- 在日常实践中,识别患有严重ICI相关毒性风险的患者仍然具有挑战性.
研究的目的:
- 开发和评估一种新的患者护理途径,用于管理ICI诱导的毒性.
- 为了能够及早发现和干预与免疫相关的不良事件.
- 改善患者的生活质量和坚持癌症治疗.
主要方法:
- 实施专门的每日毒性日间医院,用于患者评估.
- 建立一个iTox多学科委员会,以咨询专家.
- 利用药监数据库和翻译研究计划.
主要成果:
- 毒性日间医院有助于早期识别不良事件,并将其归因于抗癌治疗.
- 这种途径使得早期有毒性患者的及时管理成为可能.
- 这种结构化的方法旨在提高患者的护理和治疗结果.
结论:
- 介绍了一种整合临床评估,专科日间医院,多学科委员会和药物监测的新型护理途径.
- 这一途径支持早期检测和管理与免疫相关的不良事件,改善患者的生活质量.
- 开发的途径旨在优化瘤学中免疫治疗的益处风险平衡.
更多相关视频
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
8.9K
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
14.2K
相关概念视频
Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Cancer Vaccines
330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330
Cytotoxic T Cells-mediated Immune Response
835
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
835
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
